VEGFA and cancer: In addition, and as already mentioned, VEGF inhibitors, tyrosine kinase inhibitors (i.e., ibrutinib) and proteasome inhibitors (i.e., bortezomib, carfilzomib and ixazomib) are notorious anticancer drugs for the manifestation of arterial hypertension, including in cancer patients without pre-existing hypertensive complications.